Sarepta Therapeutics | SRPT - Vermögenswerte





Vermögenswerte Veränderung Datum
Acadia Pharmaceuticals USD 1.79B 51.25M 2026-09
Agios Pharmaceuticals USD 1.06B 44.38M 2026-09
Alnylam Pharmaceuticals USD 7.99B 2.44B 2026-09
Amgen USD 96.05B 409M 2026-09
BioCryst Pharmaceuticals USD 591.07M 33.22M 2026-09
Biogen USD 32.05B 32.5M 2026-09
BioMarin Pharmaceutical USD 11.57B 154.21M 2026-09
Capricor Therapeutics USD 330.37M 38.37M 2026-09
Daiichi Sankyo JPY 4.26T 144.08B 2026-09
Eli Lilly USD 148.07B 5.79B 2026-09
Gilead Sciences USD 51.41B 2.05B 2026-09
Incyte USD 7.29B 585.39M 2026-09
Insmed USD 2.23B 123.49M 2026-09
Ionis Pharmaceuticals USD 2.91B 81.91M 2026-09
Moderna USD 13.47B 2.51B 2026-09
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Neurocrine Biosciences USD 5.63B 268.3M 2026-09
Novavax USD 888M 67.57M 2026-09
Pfizer USD 204.54B 3.41B 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sanofi EUR 130.29B 1.23B 2026-09
Sarepta Therapeutics USD 3.17B 22.45M 2026-09
Tectonic Therapeutic USD 237.03M 9.54M 2026-06
Ultragenyx Pharmaceutical USD 1.19B 77M 2026-09
Vertex Pharmaceuticals USD 32.74B 5.31B 2026-09